Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2017

View Archived Issues

Benitec Biopharma begins work on two HNSCC programs

Onxeo and Institut Curie to study combining radiotherapy, DNA repair inhibitors and immunotherapy

Celgene reviews pipeline highlights of fourth quarter 2016

Phase I larotrectinib results presented at ECCO 2017

DOCK6 as an independent marker of tumor progression in gastric cancer

SETDB1 as a novel prognostic factor and potential therapeutic target in gastric cancer

Dimension Therapeutics reports topline results from phase I/II program of lead AAV candidate

Novel fragment-based screening platform for ligand and target discovery

Novel MN-array patch effectively regulates glucose levels and reduces risk of hypoglycemia in vivo

Grifols completes acquisition of Hologic NAT donor screening unit

Quadracel DTaP-IPV vaccine for children 4 through 6 years of age becomes available in the U.S.

Canada first to approve Kevzara

Catabasis reports topline results from Part B of MoveDMD study of edasalonexent

MediWound's phase II study of EscharEx meets primary endpoint

Novartis reviews pipeline progress of fourth quarter 2016

Merck KGaA discloses novel BTK inhibitors

Janssen Pharmaceutica identifies NR2B receptor antagonists

Japanese phase III trial of KHK-7580 in secondary hyperparathyroidism meets primary endpoint

Keytruda approved for first-line treatment of metastatic NSCLC in E.U.

Bayer patents mutant IDH1 inhibitors

Roche presents novel glutamate transporter EAAT3 inhibitors

Heptares Therapeutics launches new research collaboration with University of Cambridge

FDA accepts OptiNose's NDA for OPN-375

MISSION Therapeutics discloses novel deubiquylating enzymes inhibitors

First patient dosed in Angion Biomedica's phase II study of BB3

Spero Therapeutics acquires next-generation antibacterial candidates from Pro Bono Bio

Gemphire Therapeutics reports interim data from phase IIb study of gemcabene in HoFH

Tenax reports topline data from phase III trial of levosimendan in cardiac surgery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...